| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/07/1993 | EP0549916A2 Compounds useful as antiproliferative agents |
| 07/07/1993 | EP0549742A1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
| 07/07/1993 | EP0549723A1 Packaging cells |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |
| 07/07/1993 | EP0549660A1 Enhancement of glutathione levels with glutamine |
| 07/07/1993 | EP0542934A4 Method of treating benign and malignant proliferative skin disease |
| 07/07/1993 | EP0538330A4 Beta-alethine use in cell culture and therapy |
| 07/07/1993 | EP0412110B1 Novel vitamin d analogues |
| 07/07/1993 | EP0287633B1 Combinations of tumor necrosis factors and anti-inflammatory agents for treating malignant and non-malignant diseases |
| 07/06/1993 | US5225442 Compounds having a naphthalene structure |
| 07/06/1993 | US5225433 Selective, photosensitivity |
| 07/06/1993 | US5225420 Use of tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 07/06/1993 | US5225411 Disubstituted polymethyleneimines |
| 07/06/1993 | US5225405 Use of triazine and pyrimidine compounds for obtaining medicaments that reverse resistance to anti-cancer and anti-malarial agents |
| 07/06/1993 | US5225399 Antimicrobial amphiphilic peptides |
| 07/06/1993 | CA1319932C 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof |
| 07/06/1993 | CA1319931C Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides |
| 07/01/1993 | CA2086348A1 2-saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/01/1993 | CA2086346A1 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/30/1993 | EP0549348A1 Arylidene-heterocyclic derivatives, process for their preparation and their use as tyrisine kinase inhibitors |
| 06/30/1993 | EP0548947A1 Optically active fluorine-containing compounds |
| 06/30/1993 | EP0548834A1 Stable hexahydrate of etoposide 4'-phosphate disodium salt |
| 06/30/1993 | EP0548235A1 Synthetic drug molecules that mimic metalloenzymes |
| 06/30/1993 | CN1073683A Organic salts of N,N'-diacetyl cystine |
| 06/30/1993 | CN1073677A 20-methyl-substituted vitamin D-derivatives |
| 06/30/1993 | CN1021445C Process for preparation of steroids including a spiro ring in position 17 |
| 06/29/1993 | US5223529 N-phenylamides and medicinal products containing them |
| 06/29/1993 | US5223490 Treating breast cancer |
| 06/29/1993 | CA1319681C Platinum derivatives and cancer treatments |
| 06/29/1993 | CA1319680C Synthesis of 6-methylene derivatives of androsta-1,4-diene-3,17-dione |
| 06/25/1993 | WO1993012806A1 A method for the treatment of tumours and sarcomas |
| 06/24/1993 | WO1993012140A1 Peptide with cell adhesion activity and polymeric modification thereof |
| 06/24/1993 | WO1993012092A1 Highly water soluble bis-naphthalimides useful as anticancer agents |
| 06/24/1993 | WO1993012083A1 22-oxacholecalciferol derivative and production thereof |
| 06/24/1993 | WO1993012081A1 20-methyl-substituted vitamin d derivates |
| 06/24/1993 | WO1993011780A1 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed |
| 06/24/1993 | WO1993011770A1 Treatment of colorectal cancer |
| 06/24/1993 | WO1993011755A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 06/24/1993 | WO1993011668A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | DE4241128A1 Transdermal aspirin dosage forms - for antithrombotic therapy or cancer prophylaxis |
| 06/24/1993 | CA2125293A1 Treatment of colorectal cancer |
| 06/24/1993 | CA2125279A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | CA2125190A1 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed |
| 06/24/1993 | CA2125142A1 Highly water soluble bis-naphthalimides useful as anticancer agents |
| 06/23/1993 | WO1993011757A1 Drug formulations for parenteral use |
| 06/23/1993 | EP0547691A1 The use of 17B-N-mono-substituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones for the preparation of a medicament for the prevention of prostatic carcinoma |
| 06/23/1993 | EP0547690A1 Use of 17B-acyl-4-aza-5alpha-androst-1-en-3-ones for the preparation of a medicament for the prevention of prostatic carcinoma |
| 06/23/1993 | EP0547672A2 Inhibitors of farnesyl protein transferase |
| 06/23/1993 | EP0547671A2 Inhibitors of farnesyl protein transferase |
| 06/23/1993 | EP0547670A2 Inhibitors of farnesyl protein transferase |
| 06/23/1993 | EP0547669A2 Inhibitors of farnesyl protein transferase |
| 06/23/1993 | EP0547517A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation |
| 06/23/1993 | EP0547179A1 Triarylethylene carboxylic acids with estrogenic activity |
| 06/23/1993 | EP0547178A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 06/23/1993 | EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 06/23/1993 | EP0547165A1 Water soluble camptothecin analogues, processes and methods |
| 06/23/1993 | EP0249635B1 Word recognition in a speech recognition system using data reduced word templates |
| 06/23/1993 | CN1073447A Kedarcidin antitumor chromophore |
| 06/23/1993 | CN1073437A Pharmaceutical compounds |
| 06/23/1993 | CN1073358A Improved freeze drying isocyclophosphamide composite |
| 06/23/1993 | CN1073357A Tocotrienols and tocotrienol-like compounds and methods for their use |
| 06/22/1993 | CA1319364C Fused heterocyclic compounds |
| 06/22/1993 | CA1319362C 4-substituted androstendione derivatives and process for their preparation |
| 06/22/1993 | CA1319321C Pharmaceutical preparations |
| 06/21/1993 | CA2085299A1 5-deaza-10-oxo- and 5-deaza-10-thio-5, 6, 7, 8-tetrahydrofolic acids |
| 06/21/1993 | CA2085297A1 Sulfonimidamides |
| 06/21/1993 | CA2084469A1 Antitumor compositions and methods of treatment |
| 06/18/1993 | EP0597845A4 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2. |
| 06/18/1993 | CA2084798A1 Method of preventing prostatic carcinoma with 17beta -acyl-4-aza-5.- androst-1-ene-3-ones |
| 06/17/1993 | DE4141746A1 20-methyl-substituierte vitamin d-derivate 20-methyl-substituted vitamin d derivatives |
| 06/17/1993 | CA2085283A1 Inhibitors of farnesyl protein transferase |
| 06/17/1993 | CA2085282A1 Inhibitors of farnesyl protein transferase |
| 06/17/1993 | CA2084796A1 Inhibitors of farnesyl protein transferase |
| 06/17/1993 | CA2084795A1 Inhibitors of farnesyl protein transferase |
| 06/16/1993 | EP0546763A1 Antitumor compositions and methods of treatment |
| 06/16/1993 | EP0546634A2 Tumor associated monoclonal antibody 88BV59 |
| 06/16/1993 | EP0546591A2 11-beta-substituted 14,17-ethanoestratrienes, process for their production and their use in the preparation of medicines |
| 06/16/1993 | EP0546124A1 Multidomain hematopoiesis stimulators |
| 06/16/1993 | EP0546122A1 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
| 06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
| 06/16/1993 | EP0290558B1 Antifolate agents |
| 06/16/1993 | CN1073179A Novel glycoside compounds and production and use thereof |
| 06/15/1993 | US5220026 Antitumor agents |
| 06/15/1993 | US5220017 Gastrointestinal, central nervous system disorders |
| 06/15/1993 | US5220014 Inhibit protein synthesis |
| 06/15/1993 | US5220002 Deacetylcolchicine derivatives |
| 06/15/1993 | US5220001 Anthracycline glycoside derivatives |
| 06/15/1993 | US5219866 Antitumor agents |
| 06/15/1993 | US5219854 Administering 3/2H/-pyridazinone compound |
| 06/15/1993 | US5219846 Treatment of human tumors utilizing compounds having a phosphoamides linkage or enol phosphate linkage |
| 06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
| 06/15/1993 | US5219565 Treatment of primary cancers of the pleura |
| 06/15/1993 | US5219548 Used for selectively binding estrogen receptors of a tissue |
| 06/14/1993 | CA2083542A1 Tumor associated monoclonal antibody 88bv59 |
| 06/13/1993 | WO1993011776A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/13/1993 | CA2124565A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/11/1993 | CA2084470A1 Antitumor compositions and methods of treatment |